FDA Inspection 1073423 — PPD Development, LP

PPD Development, LP — FEI 3011410938

The FDA completed an inspection of PPD Development, LP on Nov 2, 2018 in Austin, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 2, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Austin, TX (United States)

Additional Details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.